Recruiting Multiple Myeloma Studies in Hefei
About Multiple Myeloma Clinical Trials in Hefei
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 1 multiple myeloma clinical trials recruiting participants in Hefei, ANHUI. These studies are seeking a combined 211 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Hefei — FAQ
Are there multiple myeloma clinical trials in Hefei?
Yes, there are 1 multiple myeloma clinical trials currently recruiting in Hefei, ANHUI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hefei?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hefei research site will contact you about next steps.
Are clinical trials in Hefei free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hefei studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 1 active trials in Hefei are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated March 2, 2026 from ClinicalTrials.gov